Kirkland Advises KKR on Purchase of Therapy Brands

Kirkland & Ellis counseled KKR, a leading global investment firm, on its definitive agreement to acquire a majority interest in Therapy Brands, a leading practice management and electronic health record (EHR) software platform for mental, behavioral, substance use recovery, applied behavior analysis (ABA) and physical rehabilitation healthcare providers, from its existing shareholders – investment funds affiliated with Lightyear Capital LLC, Oak HC/FT and Greater Sum Ventures. Existing investor PSG will participate in the transaction alongside KKR and continue to be a minority shareholder in Therapy Brands. Financial details of the transaction were not disclosed.

Read Therapy Brands' press release

The Kirkland team was led by corporate partners Jen Perkins, Leo Greenberg and Ari Levi and corporate associates Michael Hanna, Colin Zelicof and Heidi Quach; and debt finance partners Eric Wedel and Ryan Rafferty.